Kevin McDonnell

Company: Bicycle Therapeutics

Job title: Vice President - Chemistry

Seminars:

Bicycle Radionuclide Conjugates for precision targeting of solid tumors 10:00 am

Bicycle® molecules are a novel peptide-based modality consisting of constrained peptides that form a bi-cyclic structure via ligation to a chemical scaffold and which are discovered using the Bicycle® phage display platform and have potential broad utility, allowing efficient and targeted delivery of different classes of payloads into tumors. We are developing Bicycle Radionuclide Conjugates…Read more

day: Conference Day 2